Profile
Heikki Miettinen formerly worked at Innofinance Oy, as Investment Director & Partner from 2003 to 2016, Northern Antibiotics Oy, as Director, Zora Biosciences Oy, as Director, and Next Biomed Technologies NBT Oy, as Director.
Mr. Miettinen received his graduate degree from Aalto University.
Former positions of Heikki Miettinen
| Companies | Position | End |
|---|---|---|
Innofinance Oy
 Innofinance Oy Investment ManagersFinance Innofinance Oy (Innofinance) is an independent management-owned private equity firm founded in 1997. The firm is headquartered in Espoo, Finland. | Private Equity Investor | 2016-12-30 |
Northern Antibiotics Oy
 Northern Antibiotics Oy Pharmaceuticals: MajorHealth Technology Northern Antibiotics Oy engages in the discovery and development of novel antibiotics against multidrug-resistant gram-negative bacteria. It develops compounds, which are active against difficult-to-treat gram-negative bacteria, such as multi-resistant Escherichia coli, Klebsiella pneumoniae, other species of Enterobacteriaceae, and Acinetobacter baumannii. The company was founded by Martti Sakari Vaara and Timo Ilmari Vaara in 2003 and is headquartered in Helsinki, Finland. | Director/Board Member | - |
Next Biomed Technologies NBT Oy
 Next Biomed Technologies NBT Oy Medical SpecialtiesHealth Technology Next Biomed Technologies NBT Oy manufactured diagnostics kits. It developed novel diagnostic solutions based on multifunctional recombinant polypeptides. The company was founded by Paul Partanen in 2006 and was headquartered in Helsinki, Finland. | Director/Board Member | - |
Zora Biosciences Oy
 Zora Biosciences Oy Medical/Nursing ServicesHealth Services Zora Biosciences Oy develops biomarker-based diagnostics tests. It focuses on cardiovascular disease. The company's main product is coronary event risk test. Zora Biosciences was founded by Reini Juhani Hurme, Reijo Laaksonen, and Matej Orešic on December 14, 2006 and is headquartered in Espoo, Finland. | Director/Board Member | - |
Training of Heikki Miettinen
| Aalto University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Innofinance Oy
Innofinance Oy Investment ManagersFinance Innofinance Oy (Innofinance) is an independent management-owned private equity firm founded in 1997. The firm is headquartered in Espoo, Finland. | Finance |
Northern Antibiotics Oy
Northern Antibiotics Oy Pharmaceuticals: MajorHealth Technology Northern Antibiotics Oy engages in the discovery and development of novel antibiotics against multidrug-resistant gram-negative bacteria. It develops compounds, which are active against difficult-to-treat gram-negative bacteria, such as multi-resistant Escherichia coli, Klebsiella pneumoniae, other species of Enterobacteriaceae, and Acinetobacter baumannii. The company was founded by Martti Sakari Vaara and Timo Ilmari Vaara in 2003 and is headquartered in Helsinki, Finland. | Health Technology |
Zora Biosciences Oy
Zora Biosciences Oy Medical/Nursing ServicesHealth Services Zora Biosciences Oy develops biomarker-based diagnostics tests. It focuses on cardiovascular disease. The company's main product is coronary event risk test. Zora Biosciences was founded by Reini Juhani Hurme, Reijo Laaksonen, and Matej Orešic on December 14, 2006 and is headquartered in Espoo, Finland. | Health Services |
Next Biomed Technologies NBT Oy
Next Biomed Technologies NBT Oy Medical SpecialtiesHealth Technology Next Biomed Technologies NBT Oy manufactured diagnostics kits. It developed novel diagnostic solutions based on multifunctional recombinant polypeptides. The company was founded by Paul Partanen in 2006 and was headquartered in Helsinki, Finland. | Health Technology |
- Stock Market
- Insiders
- Heikki Miettinen
